Progyny Inc (PGNY)

Operating profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Operating income (ttm) US$ in thousands 62,184 51,690 44,756 38,410 23,341 19,847 17,657 20,475 32,340 33,689 29,452 16,724 8,348 8,331 6,572
Revenue (ttm) US$ in thousands 1,091,902 1,036,101 959,749 874,714 787,727 700,482 617,337 551,196 501,082 473,730 450,213 385,920 344,979 309,953 272,210
Operating profit margin 5.70% 4.99% 4.66% 4.39% 2.96% 2.83% 2.86% 3.71% 6.45% 7.11% 6.54% 4.33% 2.42% 2.69% 2.41%

December 31, 2023 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $62,184K ÷ $1,091,902K
= 5.70%

The operating profit margin of Progyny Inc has shown a generally increasing trend over the past eight quarters. In Q4 2023, the operating profit margin reached 5.71%, representing the highest level in the period analyzed. This improvement demonstrates the company's ability to efficiently manage its operating expenses relative to its revenue generation.

While there were fluctuations in the operating profit margin in some quarters, overall, there has been a positive trajectory in profitability. The company appears to have made efforts to control costs and optimize its operations, leading to improved margins over time.

Comparing the latest quarter to Q1 2022, the operating profit margin has increased by 1.31 percentage points, indicating a notable enhancement in profitability within the span of a year. This suggests that Progyny Inc has been successful in maximizing its operating efficiency and delivering stronger financial performance.

Overall, the upward trend in the operating profit margin reflects positively on the company's management efforts and strategic decisions aimed at enhancing profitability and creating value for its stakeholders.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating profit margin
Progyny Inc
PGNY
5.70%
DaVita HealthCare Partners Inc
DVA
13.20%
Sotera Health Co
SHC
26.37%